The 4th Annual UC San Diego Essentials and Advances in Apheresis will build on the great success of the first three conferences. The 2½-day multidisciplinary program is designed to appeal to first time attendees and to returning participants. Expert reviews of the essentials will be augmented with selected new topics and discussions of advances and innovations. The course will include nationally and internationally recognized leaders that will present didactic sessions and conduct interactive discussions.
Fundamentals will include in-depth reviews of basic principles, procedures, prescribing, clinical management, and care of special populations. There will be updates on selected disease indications will be supplemented by case studies and new clinical science. In addition, we will review plasma exchange, cell apheresis modalities, technology innovations, billing practices, and program management. The popular concurrent sessions on Frontiers in Apheresis Science and Expertise in Apheresis Practice will continue and feature new topics sessions. Furthermore, attendees will be offered hands-on workshops, led by experienced practitioners, with small-group instructions of various techniques used in therapeutic apheresis. There is also a unique opportunity for attendees to participate in the Breakfast with the Experts, which will provide them a forum to pursue specific questions and detailed discussions on various areas of interest.
The target audience for this initiative includes physicians and allied health professionals interested in therapeutic apheresis, including both established practitioners and those embarking on a new apheresis service. The content is aimed at nephrologists, hematologists, clinical pathologists, blood bankers and nurses.
Overall Program Objectives
After completing the didactic sessions, participants should be able to:
Workshop Learning Objectives
For each workshop session completed, the participant should be able to:
The 4th Annual UC San Diego Essentials and Advances in Apheresis Therapies is endorsed by: